| Title |
Enhancing skin cancer detection and classification in dermoscopic images through concatenated MobileNetV2 and Xception models / |
| Authors |
Ogundokun, Roseline Oluwaseun ; Li, Aiman ; Babatunde, Ronke Seyi ; Umezuruike, Chinecherem ; Sadiku, Peter O ; Abdulahi, AbdulRahman Tosho ; Babatunde, Akinbowale Nathaniel |
| DOI |
10.3390/bioengineering10080979 |
| Full Text |
|
| Is Part of |
Bioengineering.. Basel : MDPI. 2023, vol. 10, iss. 8, art. no. 979, p. 1-26.. ISSN 2306-5354 |
| Keywords [eng] |
data augmentation ; deep convolutional neural network ; deep learning ; skin cancer ; transfer learning |
| Abstract [eng] |
One of the most promising research initiatives in the healthcare field is focused on the rising incidence of skin cancer worldwide and improving early discovery methods for the disease. The most significant factor in the fatalities caused by skin cancer is the late identification of the disease. The likelihood of human survival may be significantly improved by performing an early diagnosis followed by appropriate therapy. It is not a simple process to extract the elements from the photographs of the tumors that may be used for the prospective identification of skin cancer. Several deep learning models are widely used to extract efficient features for a skin cancer diagnosis; nevertheless, the literature demonstrates that there is still room for additional improvements in various performance metrics. This study proposes a hybrid deep convolutional neural network architecture for identifying skin cancer by adding two main heuristics. These include Xception and MobileNetV2 models. Data augmentation was introduced to balance the dataset, and the transfer learning technique was utilized to resolve the challenges of the absence of labeled datasets. It has been detected that the suggested method of employing Xception in conjunction with MobileNetV2 attains the most excellent performance, particularly concerning the dataset that was evaluated: specifically, it produced 97.56% accuracy, 97.00% area under the curve, 100% sensitivity, 93.33% precision, 96.55% F1 score, and 0.0370 false favorable rates. This research has implications for clinical practice and public health, offering a valuable tool for dermatologists and healthcare professionals in their fight against skin cancer. |
| Published |
Basel : MDPI |
| Type |
Journal article |
| Language |
English |
| Publication date |
2023 |
| CC license |
|
